Effectiveness and safety of poly (ADP-ribose) polymerase inhibitors in cancer therapy: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Effectiveness and safety of poly (ADP-ribose) polymerase inhibitors in cancer therapy: A systematic review and meta-analysis

Published:2015-09-22 Issue:7 Volume:7 Page:7629-7639
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Bao Zhengqiang¹²,Cao Chao¹,Geng Xinwei²,Tian Baoping¹,Wu Yanping¹,Zhang Chao¹,Chen Zhihua¹,Li Wen¹,Shen Huahao¹³,Ying Songmin¹²

Affiliation:

1. Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital, Institute of Respiratory Diseases, Zhejiang University School of Medicine, Hangzhou, China

2. Department of Pharmacology, Zhejiang University School of Medicine, Hangzhou, China

3. State Key Laboratory for Respiratory Diseases, Guangzhou, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of veliparib plus chemotherapy for the treatment of lung cancer: A systematic review of clinical trials;PLOS ONE;2023-09-08

2. Simulating survival data when one subgroup lacks information;Journal of Biopharmaceutical Statistics;2023-07-26

3. S3-Leitlinie zum exokrinen Pankreaskarzinom – Langversion 2.0 – Dezember 2021 – AWMF-Registernummer: 032/010OL;Zeitschrift für Gastroenterologie;2022-11

4. The immunoregulation effect of tumor microenvironment in pancreatic ductal adenocarcinoma;Frontiers in Oncology;2022-07-28

5. Advanced Squamous Cell Carcinomas of the Pelvic and Perineal Region: A Comprehensive Genomic Profiling Study;The Oncologist;2022-07-26